{"id":{"repo_id":"wustl","oai_identifier":"oai:openscholarship.wustl.edu:etd-1656"},"canonical_url":"https://search.dev.ndltd.org/etd/wustl/oai:openscholarship.wustl.edu:etd-1656","repository":{"repo_id":"wustl","name":"Washington University in St. Louis","base_url":"https://openscholarship.wustl.edu/do/oai/"},"display":{"title":"Development Of Thymic Natural Killer Cells From Double Negative 1 Thymocyte Precursors","abstract":"While there has been much progress in defining the specificity and function of natural killer: NK) cells, their differentiation has not been fully elucidated. Previous studies of thymocyte development <italic> in vitro</italic> indicate that double negative: CD4<super>&minus</super>CD8<super>&minus</super>, DN) thymocytes can develop into cells with NK cell markers, but these cells have not been well characterized. Moreover, a subpopulation of NK cells which requires an intact thymus, i.e, thymic NK cells, has been described with selective expression of CD127 although their origin and differentiation are also poorly understood. Herein, we generated and characterized NK cells differentiating from thymic DN precursors. We enriched potential progenitors by sorting DN1: CD44<super>&plus</super>CD25<super>&minus</super>) CD122<super>&minus</super>NK1.1<super>&minus</super> thymocytes from <italic>Rag</italic>1 deficient mice for adoptive transfer into <italic>Rag</italic>1<super>&minus/&minus</super>Ly5.1 congenic mice. Following intrathymic injection, donor-derived cells phenotypically resembling thymic CD127<super>&plus</super> NK cells were found in thymus and spleen. To further characterize these cells, we seeded sorted DN1 CD122<super>&minus</super>NK1.1<super>&minus</super> thymocytes on a confluent monolayer of irradiated OP9 bone marrow stromal cells in the presence of IL15, IL7, FMS-like tyrosine kinase 3 ligand: Flt3L) and stem cell factor: SCF). Flow cytometry results showed NK1.1<super>&plus</super> cells emerged after at least 7 days in culture. By using limiting dilution analysis, we demonstrated a cell frequency of 0.24%: 1 out of 414 sorted thymocytes were able to generate an NK1.1<super>&plus</super> cell population). <italic>In vitro</italic> differentiated NK cells acquired markers associated with the development of conventional bone marrow&ndash derived splenic NK cells, but also expressed CD127, which is typically found on thymic NK cells. In-depth studies using gene chip microarrays further confirmed <italic>in vitro</italic> differentiated NK cells more closely resembled thymic NK cells as both expressed novel markers such as CD25 and CD103, which were not expressed by splenic NK cells. Finally, we found that <italic>in vitro</italic> cells generated from thymic precursors secreted cytokines when stimulated and degranulated upon target exposure, indicating that they were functional. Together, these data indicate that thymic NK cells can develop from a DN1 progenitor cell and may perhaps have a specific role that sets them apart from their splenic counterparts.","abstract_html":"While there has been much progress in defining the specificity and function of natural killer: NK) cells, their differentiation has not been fully elucidated. Previous studies of thymocyte development &lt;italic&gt; in vitro&lt;/italic&gt; indicate that double negative: CD4&lt;super&gt;&amp;minus&lt;/super&gt;CD8&lt;super&gt;&amp;minus&lt;/super&gt;, DN) thymocytes can develop into cells with NK cell markers, but these cells have not been well characterized. Moreover, a subpopulation of NK cells which requires an intact thymus, i.e, thymic NK cells, has been described with selective expression of CD127 although their origin and differentiation are also poorly understood. Herein, we generated and characterized NK cells differentiating from thymic DN precursors. We enriched potential progenitors by sorting DN1: CD44&lt;super&gt;&amp;plus&lt;/super&gt;CD25&lt;super&gt;&amp;minus&lt;/super&gt;) CD122&lt;super&gt;&amp;minus&lt;/super&gt;NK1.1&lt;super&gt;&amp;minus&lt;/super&gt; thymocytes from &lt;italic&gt;Rag&lt;/italic&gt;1 deficient mice for adoptive transfer into &lt;italic&gt;Rag&lt;/italic&gt;1&lt;super&gt;&amp;minus/&amp;minus&lt;/super&gt;Ly5.1 congenic mice. Following intrathymic injection, donor-derived cells phenotypically resembling thymic CD127&lt;super&gt;&amp;plus&lt;/super&gt; NK cells were found in thymus and spleen. To further characterize these cells, we seeded sorted DN1 CD122&lt;super&gt;&amp;minus&lt;/super&gt;NK1.1&lt;super&gt;&amp;minus&lt;/super&gt; thymocytes on a confluent monolayer of irradiated OP9 bone marrow stromal cells in the presence of IL15, IL7, FMS-like tyrosine kinase 3 ligand: Flt3L) and stem cell factor: SCF). Flow cytometry results showed NK1.1&lt;super&gt;&amp;plus&lt;/super&gt; cells emerged after at least 7 days in culture. By using limiting dilution analysis, we demonstrated a cell frequency of 0.24%: 1 out of 414 sorted thymocytes were able to generate an NK1.1&lt;super&gt;&amp;plus&lt;/super&gt; cell population). &lt;italic&gt;In vitro&lt;/italic&gt; differentiated NK cells acquired markers associated with the development of conventional bone marrow&amp;ndash derived splenic NK cells, but also expressed CD127, which is typically found on thymic NK cells. In-depth studies using gene chip microarrays further confirmed &lt;italic&gt;in vitro&lt;/italic&gt; differentiated NK cells more closely resembled thymic NK cells as both expressed novel markers such as CD25 and CD103, which were not expressed by splenic NK cells. Finally, we found that &lt;italic&gt;in vitro&lt;/italic&gt; cells generated from thymic precursors secreted cytokines when stimulated and degranulated upon target exposure, indicating that they were functional. Together, these data indicate that thymic NK cells can develop from a DN1 progenitor cell and may perhaps have a specific role that sets them apart from their splenic counterparts.","abstract_has_math":false,"creators":["Vargas, Claudia"],"institution":null,"degree_name":"Doctor of Philosophy (PhD)","degree_level":"Dissertation","degree_discipline":"Biology and Biomedical Sciences: Immunology","degree_department":null,"school":null,"contributors":["Wayne Yokoyama"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2011,"date_issued":"2011-01-01T08:00:00Z","date_published":"2011-01-01T08:00:00Z","updated_at":"2026-07-24T06:12:58Z","subjects":["Immunology","Development","Natural killer cells","Thymic NK cell"],"languages":["English (en)"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.7936/K7X63JZ0"],"render_values":[{"text":"https://doi.org/10.7936/K7X63JZ0","href":"https://doi.org/10.7936/K7X63JZ0","code":true}]}]},"links":{"outbound_url":"https://openscholarship.wustl.edu/etd/657","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Wayne Yokoyama"]},{"key":"dc:creator","label":"Author","values":["Vargas, Claudia"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2012-05-17T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biology and Biomedical Sciences: Immunology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy (PhD)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Immunology","Development","Natural killer cells","Thymic NK cell"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English (en)"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://openscholarship.wustl.edu/etd/657"]},{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.7936/K7X63JZ0"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["While there has been much progress in defining the specificity and function of natural killer: NK) cells, their differentiation has not been fully elucidated. Previous studies of thymocyte development <italic> in vitro</italic> indicate that double negative: CD4<super>&minus</super>CD8<super>&minus</super>, DN) thymocytes can develop into cells with NK cell markers, but these cells have not been well characterized. Moreover, a subpopulation of NK cells which requires an intact thymus, i.e, thymic NK cells, has been described with selective expression of CD127 although their origin and differentiation are also poorly understood. Herein, we generated and characterized NK cells differentiating from thymic DN precursors. We enriched potential progenitors by sorting DN1: CD44<super>&plus</super>CD25<super>&minus</super>) CD122<super>&minus</super>NK1.1<super>&minus</super> thymocytes from <italic>Rag</italic>1 deficient mice for adoptive transfer into <italic>Rag</italic>1<super>&minus/&minus</super>Ly5.1 congenic mice. Following intrathymic injection, donor-derived cells phenotypically resembling thymic CD127<super>&plus</super> NK cells were found in thymus and spleen. To further characterize these cells, we seeded sorted DN1 CD122<super>&minus</super>NK1.1<super>&minus</super> thymocytes on a confluent monolayer of irradiated OP9 bone marrow stromal cells in the presence of IL15, IL7, FMS-like tyrosine kinase 3 ligand: Flt3L) and stem cell factor: SCF). Flow cytometry results showed NK1.1<super>&plus</super> cells emerged after at least 7 days in culture. By using limiting dilution analysis, we demonstrated a cell frequency of 0.24%: 1 out of 414 sorted thymocytes were able to generate an NK1.1<super>&plus</super> cell population). <italic>In vitro</italic> differentiated NK cells acquired markers associated with the development of conventional bone marrow&ndash derived splenic NK cells, but also expressed CD127, which is typically found on thymic NK cells. In-depth studies using gene chip microarrays further confirmed <italic>in vitro</italic> differentiated NK cells more closely resembled thymic NK cells as both expressed novel markers such as CD25 and CD103, which were not expressed by splenic NK cells. Finally, we found that <italic>in vitro</italic> cells generated from thymic precursors secreted cytokines when stimulated and degranulated upon target exposure, indicating that they were functional. Together, these data indicate that thymic NK cells can develop from a DN1 progenitor cell and may perhaps have a specific role that sets them apart from their splenic counterparts."]},{"key":"dc:title","label":"Title","values":["Development Of Thymic Natural Killer Cells From Double Negative 1 Thymocyte Precursors"]}]}],"canonical_facts":{"dc:contributor":["Wayne Yokoyama"],"dc:creator":["Vargas, Claudia"],"dc:date.available":["2012-05-17T07:00:00Z"],"dc:description.abstract":["While there has been much progress in defining the specificity and function of natural killer: NK) cells, their differentiation has not been fully elucidated. Previous studies of thymocyte development <italic> in vitro</italic> indicate that double negative: CD4<super>&minus</super>CD8<super>&minus</super>, DN) thymocytes can develop into cells with NK cell markers, but these cells have not been well characterized. Moreover, a subpopulation of NK cells which requires an intact thymus, i.e, thymic NK cells, has been described with selective expression of CD127 although their origin and differentiation are also poorly understood. Herein, we generated and characterized NK cells differentiating from thymic DN precursors. We enriched potential progenitors by sorting DN1: CD44<super>&plus</super>CD25<super>&minus</super>) CD122<super>&minus</super>NK1.1<super>&minus</super> thymocytes from <italic>Rag</italic>1 deficient mice for adoptive transfer into <italic>Rag</italic>1<super>&minus/&minus</super>Ly5.1 congenic mice. Following intrathymic injection, donor-derived cells phenotypically resembling thymic CD127<super>&plus</super> NK cells were found in thymus and spleen. To further characterize these cells, we seeded sorted DN1 CD122<super>&minus</super>NK1.1<super>&minus</super> thymocytes on a confluent monolayer of irradiated OP9 bone marrow stromal cells in the presence of IL15, IL7, FMS-like tyrosine kinase 3 ligand: Flt3L) and stem cell factor: SCF). Flow cytometry results showed NK1.1<super>&plus</super> cells emerged after at least 7 days in culture. By using limiting dilution analysis, we demonstrated a cell frequency of 0.24%: 1 out of 414 sorted thymocytes were able to generate an NK1.1<super>&plus</super> cell population). <italic>In vitro</italic> differentiated NK cells acquired markers associated with the development of conventional bone marrow&ndash derived splenic NK cells, but also expressed CD127, which is typically found on thymic NK cells. In-depth studies using gene chip microarrays further confirmed <italic>in vitro</italic> differentiated NK cells more closely resembled thymic NK cells as both expressed novel markers such as CD25 and CD103, which were not expressed by splenic NK cells. Finally, we found that <italic>in vitro</italic> cells generated from thymic precursors secreted cytokines when stimulated and degranulated upon target exposure, indicating that they were functional. Together, these data indicate that thymic NK cells can develop from a DN1 progenitor cell and may perhaps have a specific role that sets them apart from their splenic counterparts."],"dc:identifier":["https://openscholarship.wustl.edu/etd/657"],"dc:identifier.doi":["https://doi.org/10.7936/K7X63JZ0"],"dc:language":["English (en)"],"dc:subject":["Immunology","Development","Natural killer cells","Thymic NK cell"],"dc:title":["Development Of Thymic Natural Killer Cells From Double Negative 1 Thymocyte Precursors"],"thesis:degree_discipline":["Biology and Biomedical Sciences: Immunology"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Doctor of Philosophy (PhD)"]},"updated_at":"2026-07-24T06:12:58Z"}